<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 10-Sep-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (10-Sep-2025)</h1>
<hr />
<h2>Key News Highlights</h2>
<ul>
<li><strong>Fed Rate Cuts Now Higher Probability</strong>: After a major downward revision to job growth (+911k fewer jobs than originally reported), CEOs like JPMorgan’s Jamie Dimon publicly warn of a weakening US economy. Markets expect multiple Fed rate cuts in 2025.</li>
<li><strong>Major Tech Moves</strong>: Nvidia is widely expected to remain the world’s largest company by year-end. Microsoft (with a big AI deal) and Apple (with product launches, new health features) remain prominent but less likely to overtake Nvidia in market cap.</li>
<li><strong>Supreme Court to Rule on Tariffs</strong>: SCOTUS will rule on Trump-era tariffs, which could reshape US-China/EUR supply chains, consumer prices, and US trade balance.</li>
<li><strong>Geopolitical Flashpoints Persist</strong>: Israel attempted strikes in Qatar against Hamas leadership; US–Qatar–Israel relations in flux. France faces yet another government shakeup. US–South Korea tensions rise over immigration/labor raids at Hyundai plants.</li>
<li><strong>Healthcare Sector Watch</strong>: New White House push against pharmaceutical advertising; Apple &amp; American Heart Association double down on hypertension/blood pressure monitoring tech; COVID/vaccine delivery challenges persist.</li>
<li><strong>Crypto ETF Expansion</strong>: Ripple and Dogecoin ETFs moving to regulatory approval, signaling potential widening of retail and institutional interest.</li>
</ul>
<hr />
<h2>A. Macro and Policy</h2>
<h3>1. Fed Policy, Rates &amp; Recession</h3>
<ul>
<li>Markets are growing confident the Fed will cut rates 2–3 times in 2025, with almost no expectation of hikes or emergency cuts.</li>
<li>Likelihood of a US recession this year is low, but recent BLS payroll revisions and C-suite warnings (Dimon) indicate the economy is less robust than previously thought.</li>
<li>Lower job creation puts additional pressure on the Fed to ease, supporting equities and risk assets—at least in the short run.</li>
<li>Inflation is expected to stay controlled, with little fear of a spike above 5% in 2025.</li>
<li><strong>Second-Order Effects</strong>: Dovish policy could weaken the dollar and reflate risk assets, but also risk keeping “zombie” companies afloat. Persistent low inflation expectations will likely anchor real yields, impacting fixed income and TIPS return expectations.</li>
<li><strong>Geopolitical overlay</strong>: Supreme Court decision on Trump tariffs could cause a discrete shock or relief to supply chains, commodities, and consumer inflation if tariffs are voided or upheld.</li>
</ul>
<h3>2. Geopolitics and Regulation</h3>
<ul>
<li><strong>Middle East risk</strong> (Israel, Qatar, Iran proxies) and renewed focus on US–Asian trade/labor frictions (Hyundai situation) create overhangs for exports/imports, energy, and auto supply chains.</li>
<li><strong>France’s political turbulence</strong> and leadership change (Lecornu as new PM) could signal fiscal/military stance shifts for the EU, potentially impacting eurozone assets and defense/energy sectors.</li>
<li><strong>US domestic policy</strong>: Tariff litigation, pharma advertising crackdown, and tightening on labor/immigration could reshape specific sectors’ profit pools and regulatory burdens.</li>
</ul>
<hr />
<h2>B. Sectors</h2>
<h3>1. Technology &amp; AI</h3>
<ul>
<li>Nvidia very likely remains the dominant public AI play, with broad strength in semis/rack server supply chains.</li>
<li>Microsoft’s $17B AI deal with Nebius highlights ongoing migration to AI-native cloud partners—expect tailwinds for infrastructure and mid-tier AI “arms dealers.” Nebius and similar second-tier AI enablers may see outsized performance.</li>
<li>Apple’s event focused on health (hypertension, pulse monitoring) and new device forms may support premium hardware demand despite looming tariff noise. Lack of CEO turnover at Apple/Microsoft/Google reduces headline risk.
<ul>
<li><strong>Potential rotation</strong>: Outperformance could continue for major AI and health-tech names; traditional large-cap techs like Apple and Microsoft may lag Nvidia absent major product or strategy shifts.</li>
</ul>
</li>
</ul>
<h3>2. Healthcare &amp; Biotech</h3>
<ul>
<li>Pharma advertising clampdown could compress marketing spend/leverage sector margins. However, Apple/Watch push into hypertension management and “health at home” blurs lines between medtech, wearables, and traditional healthcare players.</li>
<li>Public health headlines (COVID vaccine confusion, new AHA blood pressure guidelines, “kissing bug”/Chagas disease alarm) could drive renewed interest in vaccine, diagnostics, and healthtech stocks.</li>
<li><strong>Longer-term</strong>: Watch for payer/provider tension as consumer tech giants encroach on traditional healthcare business models.</li>
</ul>
<h3>3. Energy, Materials &amp; Commodities</h3>
<ul>
<li>Supreme Court’s tariff ruling carries significant implications for US energy and materials importers. A decision against tariffs could lower input costs for US manufacturers at the margin; a decision to uphold would reinforce the risk of supply chain nationalism.</li>
<li>Ethiopia’s GERD dam (Africa’s largest) now active—regional tensions (Egypt/Sudan) over water and energy could push up energy and food commodity risk premia in MENA-adjacent ETFs.</li>
</ul>
<h3>4. Crypto &amp; Digital Assets</h3>
<ul>
<li>Bitcoin and Ethereum pricing reflect expectations for continued institutionalization and new ETF approvals—Ripple and Dogecoin ETFs look all but certain, opening fresh retail and institutional inflows.</li>
<li>Crypto’s “moonshot” predictions are dismissed as unlikely, but mid-tier price targets ($130k BTC, $5k ETH) seem in play.</li>
<li>Macro conditions (lower Fed rates, stable inflation) are supportive, but any rapid Fed or risk-off turn could prompt sharp crypto retrenchment.</li>
</ul>
<hr />
<h2>C. Notable Individual Names and Storylines</h2>
<ul>
<li><strong>Nvidia</strong>: Well positioned to finish the year as the largest public company; positive feedback loop from AI/cloud demand and investor flows. Risk is mainly around sector-wide derating rather than specific to NVDA.</li>
<li><strong>Apple</strong>: iPhone/Watch refresh targets health ecosystem. Price discipline signals margin defense; no management change expected in 2025, minimizing “transition” distractions.</li>
<li><strong>Microsoft</strong>: AI expansion outside usual partners (Nebius deal) keeps the narrative bullish even if cloud growth softens.</li>
<li><strong>Tesla</strong>: Out of contention for global market cap leadership; no current management turmoil, but recent news topics are tangential to fundamentals (unrelated legal/personal incidents).</li>
<li><strong>Coinbase, Amazon, Google</strong>: CEO changes seen as very unlikely.</li>
<li><strong>Hyundai</strong>: US labor/immigration enforcement creates supply chain, PR, and diplomatic headaches—corporate operating risk heightened for cross-border manufacturers.</li>
</ul>
<hr />
<h2>Actionable Takeaways</h2>
<ol>
<li><strong>Macro</strong>: Stay overweight risk assets, but monitor for surprises from Supreme Court, Fed, and BLS data—softness in labor could accelerate cyclical rotation.</li>
<li><strong>Tech/AI</strong>: Position for Nvidia leadership—AI hardware and “cloud AI” beneficiaries. Second-tier AI and data center ecosystem stocks could surprise on the upside.</li>
<li><strong>Healthcare</strong>: Watch for regulation in pharma ads and the rapid bleed-in of healthtech (Apple et al.) into mainstream medical markets.</li>
<li><strong>Crypto</strong>: Core crypto assets face benign macro headwinds, but extreme melt-up scenarios are low-probability. Regulatory/ETF news could spark sector-wide rallies.</li>
<li><strong>Geopolitics/Energy</strong>: Tariffs, Middle East, and new leadership in France add volatility potential; keep dry powder for event-driven swings.</li>
</ol>
<hr />

</main>
</body>
</html>
